Cargando…
Adaptive dosing of anticancer drugs in neonates: facilitating evidence-based dosing regimens
PURPOSE: Selection of the most appropriate chemotherapy dosing regimens for neonates treated within the first weeks of life represents a significant clinical dilemma. Due to a lack of information relating to the clinical pharmacology of anticancer drugs in these challenging patients, current dosing...
Autores principales: | Veal, Gareth J., Errington, Julie, Sastry, Jairam, Chisholm, Julia, Brock, Penelope, Morgenstern, Daniel, Pritchard-Jones, Kathy, Chowdhury, Tanzina |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Springer Berlin Heidelberg
2016
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4819938/ https://www.ncbi.nlm.nih.gov/pubmed/26875154 http://dx.doi.org/10.1007/s00280-016-2975-0 |
Ejemplares similares
-
Generation of evidence-based carboplatin dosing guidelines for neonates and infants
por: Barnett, Shelby, et al.
Publicado: (2023) -
Simplified Dosing Regimens for Gentamicin in Neonatal Sepsis
por: D’Agate, S., et al.
Publicado: (2021) -
Pharmacokinetics and Pharmacogenetics of Cyclophosphamide in a Neonate and Infant Childhood Cancer Patient Population
por: Barnett, Shelby, et al.
Publicado: (2021) -
Vincristine dosing, drug exposure and therapeutic drug monitoring in neonate and infant cancer patients
por: Barnett, Shelby, et al.
Publicado: (2022) -
Prospective validation of neonatal vancomycin dosing regimens is urgently needed
por: Vandendriessche, Anaïs, et al.
Publicado: (2014)